Founder | Apteka Policy
Jennifer Snow is a health care professional with over 20 years of experience in policy and reimbursement with a focus on pharmaceuticals.
As the Founder of Apteka, she advises clients on health care policy and market trends at the federal and state level. She is a subject matter expert on many topics including the Inflation Reduction Act, the Affordable Care Act, 340B, supply chain dynamics, pharmacy benefit managers and federal health programs, particularly the Medicare Prescription Drug Benefit (Part D). Jennifer has presented nationally for health plan, payer, patient and pharmaceutical audiences and has experience in various therapeutic areas including cardiovascular, respiratory, mental health, diabetes, oncology and rheumatoid arthritis.
Prior to founding Apteka, Jennifer was a Vice President of Market Economics at AmerisourceBergen. There she conducted analysis and distilled key trends for internal and external stakeholders with a focus on the Inflation Reduction Act, 340B and biosimilars. She also served as Vice President of the Reimbursement Policy Insights group at Xcenda, AmerisourceBergen’s consulting division. At Xcenda, Jennifer served as a thought leader and led the organization’s consulting work in policy and reimbursement space working with dozens of large and small biopharmaceutical organizations, patient groups and industry associations. Earlier, Jennifer was part of AstraZeneca’s executive branch advocacy team and worked closely with Managed Markets, brand teams and Medical Affairs. Jennifer also worked for the Centers for Medicare & Medicaid Services on the Essential Health Benefit as well as Avalere Health and Stanford University. During her tenure at Stanford, she implemented both a consumer-driven health plan and a pharmacy benefit manager program.
Jennifer holds an MPH from the University of North Carolina-Chapel Hill and a B.S. in Russian from Georgetown University
